These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 9230884

  • 1. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

  • 2. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.
    Zangemeister-Wittke U, Schenker T, Luedke GH, Stahel RA.
    Br J Cancer; 1998 Oct 16; 78(8):1035-42. PubMed ID: 9792147
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 4. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O, Tschopp S, Olie RA, Leech SH, Simões-Wüst AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 2001 Mar 21; 93(6):463-71. PubMed ID: 11259472
    [Abstract] [Full Text] [Related]

  • 5. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U, Leech SH, Olie RA, Simões-Wüst AP, Gautschi O, Luedke GH, Natt F, Häner R, Martin P, Hall J, Nalin CM, Stahel RA.
    Clin Cancer Res; 2000 Jun 21; 6(6):2547-55. PubMed ID: 10873111
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.
    Loriot Y, Mordant P, Brown BD, Bourhis J, Soria JC, Deutsch E.
    Anticancer Res; 2010 Oct 21; 30(10):3869-78. PubMed ID: 21036697
    [Abstract] [Full Text] [Related]

  • 7. Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides.
    Gleave ME, Miayake H, Goldie J, Nelson C, Tolcher A.
    Urology; 1999 Dec 21; 54(6A Suppl):36-46. PubMed ID: 10606283
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.
    Mol Urol; 2001 Dec 21; 5(2):71-8. PubMed ID: 11690551
    [Abstract] [Full Text] [Related]

  • 9. Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model.
    Leung S, Miyake H, Zellweger T, Tolcher A, Gleave ME.
    Int J Cancer; 2001 Mar 15; 91(6):846-50. PubMed ID: 11275990
    [Abstract] [Full Text] [Related]

  • 10. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC.
    Clin Cancer Res; 2003 Jul 15; 9(7):2826-36. PubMed ID: 12855663
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B.
    J Natl Cancer Inst; 1997 Jan 15; 89(2):124-33. PubMed ID: 8998181
    [Abstract] [Full Text] [Related]

  • 12. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun 15; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.
    Leech SH, Olie RA, Gautschi O, Simões-Wüst AP, Tschopp S, Häner R, Hall J, Stahel RA, Zangemeister-Wittke U.
    Int J Cancer; 2000 May 15; 86(4):570-6. PubMed ID: 10797273
    [Abstract] [Full Text] [Related]

  • 14. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
    Wang J, Liu X, Jiang W.
    Chin Med J (Engl); 2000 Oct 15; 113(10):957-60. PubMed ID: 11775848
    [Abstract] [Full Text] [Related]

  • 15. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion].
    Zheng JM, Wang DK, Jiang HM.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec 15; 25(12):1537-9. PubMed ID: 16361157
    [Abstract] [Full Text] [Related]

  • 16. In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability.
    Santos AO, Pereira JP, Pedroso de Lima MC, Simões S, Moreira JN.
    Braz J Med Biol Res; 2010 Oct 15; 43(10):1001-9. PubMed ID: 20922271
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 15; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1674-80. PubMed ID: 7473815
    [Abstract] [Full Text] [Related]

  • 19. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
    Jason TL, Figueredo R, Ferguson PJ, Vincent MD, Berg RW, Koropatnick J.
    DNA Cell Biol; 2008 May 15; 27(5):229-40. PubMed ID: 18358073
    [Abstract] [Full Text] [Related]

  • 20. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.
    Miayake H, Tolcher A, Gleave ME.
    J Natl Cancer Inst; 2000 Jan 05; 92(1):34-41. PubMed ID: 10620631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.